Article
Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.
BMC research notes - 9 Dec 2016
Kudzi William, Ahorhorlu Samuel Yao, Dzudzor Bartholomew, Olayemi Edeghonghon, Nartey Edmund Tetteh, Asmah Richard Harry
Abstract excerpt
BACKGROUND: Warfarin is a widely prescribed anticoagulant with narrow therapeutic window for thromboembolic events. Warfarin displays large individual variability in dose requirements. The purpose of this study is to assess the contribution of patient-specific and genetic risk factors to dose requirements of patients on either high or low warfarin maintenance dose in Ghana. Blood samples were collected from 141...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
